Connect with us

Life Sciences

New Culture is “Redefining the Boundaries of What’s Possible in Dairy” with Significant Upscaling of Animal-Free Mozzarella

California startup New Culture announces that it has successfully increased the production of its precision fermentation platform to a much larger scale…

Published

on

This article was originally published by Vegeconomist

California startup New Culture announces that it has successfully increased the production of its precision fermentation platform to a much larger scale and additionally has achieved a reduction of 80% in product cost. According to the company, it has managed to produce enough animal-free casein in a single run to make cheese for 25,000 pizzas.

Founded in 2019, New Culture makes animal-free mozzarella by combining traditional cheese-making methods and casein proteins derived from precision fermentation. The company debuted its revolutionary cheese in June at Nancy Silverton’s Pizzeria Mozza in Los Angeles — where New Culture’s mozzarella will officially launch in 2024 before expanding to other pizzerias nationwide. 

“We are entering an era where we can produce massive amounts of real cheese without the involvement of any animals”

New Culture has received financial support from companies, including Kraft Heinz, ADM, and biotech giant CJ CheilJedang, to develop further its innovative platform that allows the production of any type of cheese without using animal-based ingredients.

New Culture Cheese Pizza lifestyle
© New Culture

Scaling casein for 14 million pizzas

Reaching this production milestone marks a significant step in offering a dairy-free alternative to traditional mozzarella to pizzerias throughout America. According to the startup, it’s the first time in the world that a company produces recombinant casein at such a scale.

“Our world-class team at New Culture has solved a string of incredibly complex technical challenges in order to produce our animal-free casein at this scale,” says Inja Radman, co-founder and CSO of New Culture. 

After this milestone in its production capacity, New Culture says it has achieved a reduction of 80% in its product cost, reaching its targets. And the company predicts that within three years, it could expand its biomanufacturing capacities to make its animal-free mozzarella reach price parity with conventional dairy cheese. It expects to produce enough casein to make cheese for more than 14 million pizzas annually. 

“We are redefining the boundaries of what’s possible in dairy in a way that isn’t being done anywhere else,” Radman adds.

animal free mozzarella cheese being grated by a woman
© New Culture

A new sustainable era

As it continues to scale manufacturing capabilities, New Culture is paving the way for a new industry with far-reaching implications for environmental sustainability, animal welfare, and human health. 

Traditional cheese production method consumes a significant amount of water and energy resources. And the terrible condition of animals in the dairy industry has been raising ethical concerns worldwide. But New Culture’s animal-free mozzarella requires a fraction of these resources, while precision fermentation eliminates the need to use animal products while allowing consumers to enjoy their favorite cheeses. 

“This achievement marks a pivotal moment for New Culture and the food industry. We are entering an era where we can produce massive amounts of real cheese without the involvement of any animals,” says Matt Gibson, co-founder and CEO of New Culture.

Read Matt Gibson’s recent Op Ed on precision fermentation here.

manufacturing

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending